×

ABOUT

Achieve more perspective

Join us in our mission to provide AI-powered pathology anywhere, anytime

At Aiosyn, we are committed to advancing precision pathology in cancer and kidney diseases through artificial intelligence. We develop software solutions that inject deep-learning algorithms into existing workflows to provide data-driven insights that ultimately improve patient outcomes.

With our AI-powered technology, we want to offer pathology labs and biopharma companies new perspectives to discover the most effective treatments while optimizing workflow efficiency.

Meet the team

We bring AI technology to patients

Aiosyn’s team is a unique mix of talented scientists, engineers, regulatory, medical and business professionals that aim to bring computational pathology technology to patients and doctors.

Meet the Team

Jeroen van der Laak

Chief Scientific Officer

David Tellez

Chief Technology Officer

Wouter Bulten

Chief Operating & Product Officer

Patrick de Boer

Chief Executive Officer

Aiosyn is rooted in pathology

Aiosyn was founded as a spin-off from the Computational Pathology research group of Radboud University Medical Center, one of the front-runners in the field. We build upon 20+ years of research experience in the field of pathology and are proud to say that we are rooted in pathology practice. With our track-record in artificial intelligence and software engineering we bring research innovations into the hands of pathologists.

Our close connection to clinical practice allows us to build computational pathology solutions for and together with pathologists. We believe in the power of AI to empower pathologists and envision a world where AI is available everywhere, anytime.

See our Solutions

The role of AI in digital pathology

AI is revolutionizing pathology by enhancing diagnostic accuracy, streamlining workflows, and ultimately improving patient care. One impactful application is the analysis of digital pathology images. By training AI algorithms to detect specific features in whole slide images, such as cells undergoing division, these tools can provide precise quantitative measurements that aid in diagnosis. Additionally, AI has the ability to analyze vast amounts of data to identify patterns and abnormalities that might be missed by the human eye.

These advancements are transforming clinical practice and drug development, enabling more precise diagnoses and personalized treatments while reducing the time spent on manual review. This enhances efficiency and diagnostic consistency, contributing to the democratization of healthcare and ultimately improving patient outcomes.

At Aiosyn, we are dedicated to developing and integrating deep-learning solutions into existing pathology workflows, facilitating the adoption of AI in pathology, and empowering pathologists to deliver faster, more precise care.

Book a demo